top of page

About Us

tVNS Health Gmbh is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy.

The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients' quality of life.

NRVVT - Design stock  (1).png
NRVVT - Design stock  (1).png
NRVVT - Design stock  (1).png

Meet the Founders

draft çalışmalar.png

Berkay Gezen is an enthusiastic professional with 28+ global business development and medical brand management. He has served as the global commercial director of CardiAid, brand for 11 years, from the design of the brand to its expansion in over 65 countries of the world.

Following his creative vision of AED and his experience in global development, he became the founder of tVNS Health to focus on neuromodulation and vagus nerve stimulation technologies, sales, services and distribution for tVNS.
With his expertise in market building, he become the implementer of projects that make a difference in more than 80 countries of the world.
He has dedicated his professional life to increasing the awareness of public access defibrillators  and neuromodulation.  With his motivation, he inspires the medical community and continues to manage medical channel in more than 50 countries worldwide.

Berkay Gezen

WhatsApp Görsel 2024-04-01 saat 11.34.28_3a78a622.jpg

Selin Erdogan Gezen

She is a visionary leader in the field of neuromodulation technologies and global business development. After pivotal roles in renowned companies like Vodafone, Garanti BBVA Bank, and Hewlett Packard, as program management in innovative technology projects, Selin embarked on a new chapter as a founding partner of Nervovita Medical Technologies and tVNS Health, focusing on neuromodulation therapies.

Her dedication led to the accessibility of transcutaneous vagal nerve stimulation, revolutionizing treatment options around the globe.

She collaborates with leading universities and institutes in over 40 countries, driving clinical studies across various diseases.

She is designing the human-machine interaction for better usability of wearable medical devices.

enhanced (8).jpg

"Our mission is to empower individuals worldwide with innovative neuromodulation and bio-electronic solutions that enhance well-being and improve lives. Committed to advancing healthcare through cutting-edge technology, we strive to be the global leader in distributing the transcutaneous vagus nerve stimulation devices.

Guided by a dedication to excellence, integrity, and social responsibility, our company aims to establish a pervasive presence in the global market, ensuring accessibility to the transformative benefits of the tVNS devices. We are driven by a passion for improving mental and physical health, fostering a world where individuals can achieve their full potential and lead fulfilling lives.

Our commitment extends beyond the distribution; we aim to build enduring partnerships with healthcare professionals, research institutions, and distributors to foster a collaborative ecosystem. By prioritizing customer satisfaction, continuous innovation, and ethical business practices, we aim to create a positive impact on the well-being of communities around the globe."

 

Our Mission

Our Vision

"We envision a future where transformative neuromodulation technology becomes an integral part of global healthcare, revolutionizing the way individuals manage and enhance their well-being. Guided by innovation, compassion, and a commitment to excellence, we aspire to establish ourselves as the foremost global influence, ensuring universal access, recognition, and trust in the widespread expansion of transcutaneous vagus nerve stimulation technologies (taVNS).

We aspire to lead the charge in advancing the field of neuromodulation, continuously pushing the boundaries of what is possible to unlock the full potential of the human body's innate healing mechanisms. By fostering a culture of curiosity, collaboration, and inclusivity, we aim to inspire a global movement toward proactive and personalized healthcare solutions.

Through strategic partnerships, ongoing research, and a commitment to ethical business practices, we seek to shape a healthcare landscape where preventative and holistic approaches are celebrated.

As we strive for excellence, our vision extends beyond business success to contributing significantly to the betterment of society. We see a world where the neuromodulation becomes a beacon of hope, fostering resilience, and promoting a culture of well-being that transcends borders.

We are dedicated to pioneering a future where the power of neuromodulation transforms lives, creating a healthier, happier, and more connected global community."

tVNS Health GmbH
Headquarter

Südliche Münchner Str. 62, 82031 Grünwald, Germany 

info@tvns.health

www.tvns.health

  • Instagram
  • YouTube
  • Facebook
tVNS
bottom of page